Publications on ITP

Antibody Therapy   Substitution- Immunomodulation- Monoclonal Immunotherapy 

Editor: Imbach, Paul (Ed.)

See some details/Buy....


Supplement to Seminars in Hematology on the 5th Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting in Flüeli-Ranft, Switzerland, September 2015 


 Volume 53, Supplement 1, Pages A1-A4, S1-S72 (April 2016)

 Table of Content



Supplement to Seminars in Hematology on the 4th Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting in Montreux, Switzerland, September 2012 

Vol. 50 January, 2013 p.S1-S126, Supplement 1

Table of Content


Thrombopoietin-Receptor Agonists for Primary Immune Thrombocytopenia, NEW ENGLAND JOURNAL of MEDICINE, August 2011  

Paul Imbach, M.D., and Mark Crowther, M.D.


Immune Thrombocytopenia (ITP) (Editor). UNI-MED Verlag Bremen, London, Boston, 2010, 2nd edition 2013

Kühne T.





Editorial 3rd Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting in Basel, Switzerland, September 2009

Thomas Kühne and Paul Imbach


Annals of Hematology, Volume 89, Supplement 1/ July 2010



Kühne T
Imbach P

Editorial 3rd Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting in Basel, Switzerland, September 2009 

Clemetson KJ
Panzer S

The working group for “basic science” in ITP at the International Cooperative ITP Study Group (ICIS)

Tamary H
Roganovic J et al.

Consensus Paper—ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia  

Grainger JD
Bolton-Maggs PHB et al.

Diagnosis and management of chronic ITP: comments from an ICIS expert group

Zehnder JL
JW et al.

Future research in ITP: an ICIS consensus

Biburger M
Aschermann S et al. 

The role of Fcγ receptors in murine autoimmune thrombocytopenia

Pang  SJY

Mechanisms of platelet recovery in ITP associated with therapy

Semple JW 

Animal models of immune thrombocytopenia (ITP)

Speer O

Investigating caspases and other markers of apoptosis in ITP

Neunert CE 

Evaluating bleeding severity in immune thrombocytopenia (ITP)

Klaassen RJ
Young NL 

Health-related quality of life outcomes for patients with immune thrombocytopenic purpura

Godeau B
Michel M 

Treatment of chronic immune thrombocytopenic purpura in adults

Bolton-Maggs PHB

Chronic immune thrombocytopenic purpura—who needs medication? 

Kühne T
Imbach P 

Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia

Jawa V
Hokom M et al. 

Assessment of immunogenicity of romiplostim in clinical studies with ITP subjects

Wadenvik H
Olsson B 

Moving towards a new era in the management of chronic immune thrombocytopenia

Bergmann AK

Grace RF
Neufeld EJ

Genetic studies in pediatric ITP: outlook, feasibility, and requirements

Kühne T

ICIS supplementum abstracts





The Special Issue of Pediatric Blood & Cancer on the 2nd Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting on "Critical Issues and Future Research of ITP", September 16-18, 2006, in Yverdon-les-Bains, Switzerland, is now available online.

Pediatric Blood & Cancer 2006, Volume 47, Issue S5, p 649- 745.

Kühne T

2nd Expert Meeting 2006 on critical issues and future development of research in ITP

Kühne T

Idiopathic thrombocytopenic purpura in childhood, controversies and solutions

Ruggeri M.

Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura in childhood: A critical appraisal from literature analysis

Hazzan R

Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura

Nilsson C

Studies of chronic ITP in children and adolescents

Roganovic J

Idiopathic thrombocytopenic purpura: A 15year natural history study at the Children's Hospital Rijeka, Croatia

Baronci C

Idiopathic thrombocytopenic purpura (ITP) in children

Gaedicke G.

Some unsettled questions in childhood thrombocytopenia caused by immunologic platelet destruction (acute and chronic ITP)

Culic S.

Correlations among age, cytokines, lymphocyte subtypes, and platelet counts in autoimmune thormbocytopenic purpura

Sood R

Gene expression profile in idiopathic thrombocytopenic purpura (ITP)

Rischewski J

Idiopathic Thrombocytpenic Purpura (ITP): Is there a genetic predisposition?

Buchanan G

Current challenges in the management of children with idiopathic thrombocytopenic purpura

Imbach P

Development and Research in idiopathic thrombocytopenic purpura – An inflammatory and autoimmune disorder

Bessho F

Guideline of management for childhood ITP

Mackensen S.

Development of a disease-specific auality of life questionnaire for children & adolescents with idiopathic thrombocytopenic purpura (ITP-QoL)

Wainwright RD

Psychosocial aspects of immune thrombocytopenia and secondary human immunodeficiency virus-related pediatric immune thrombocytopenia in the Republic of South Africa

Panzer S

Flow cytometric evaluation of platelet activation in chronic autoimmune thrombocytopenia

Tomer A

Autoimmune thrombocytopenia: Determination of platelet specific autoantibodies by flow cytometry

Salama A

A novel agglutination test for antigen-specific detection of platelet antibodies

Koene H.

Critical issues of current and future developments in the treatment of immune thrombocytopenic purpura

Bennett C.

Targeted ITP strategies: do they elucidate the biology of ITP and related disorders?

Crow A

Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia

Tamminga R

Rituximab treatment for symptomatic chronic ITP

Kjaersgaard M

A review of anti-D treatment of childhood idiopathic thrombocytopenic purpura

Meyer O

Replacement of intravenous administration of anti-D by subcutaneous administration in patients with autoimmune thrombocytopenia

Nichol J

AMG 531: An investigational thrombopoiesis-stimulating peptibody (TSP)

Miale T

Multimodal management including precisely targeted irradiation in a severe refractory case of Evans Syndrome

Wrobel G

Experiences with recombinant activated factor VII in the treatment of severe, refractory thrombocytopenia

El Alfy M.

Prospective evaluation of high cost management of severe chronic ITP in children and adolescents < 16 years

Minkov M

Critical issues concerning splenectomy for chronic idiopathic thrombocytopenic purpura in childhood

Donato H

Splenectomy and spontaneous remission in children with chronic idiopathic thrombocytopenic purpura

Kaplinsky C.


Post-splenectomy antibiotic prophylaxis –unfinished story: To treat or not to treat?

Ramenghi U.

Splenectomy in children with chronic ITP: Long-term efficacy and relation between its outcome and responses to previous treatments

Order on Wiley InterScience

Intercontinental Cooperative ITP Study Group (ICIS):
State of the Art Expert Meeting on ITP, September 23-25, 2003, Bürgenstock Switzerland
J Pediatr Hematol Oncol. 2003 Dec;25 Supplement 1





Imbach P et al.

Overview of the State of the Art Expert Meeting of the Intercontinental Cooperative ITP Study Group (ICIS)

Chanock S

The etiology of Childhood Immune Thrombocytopenic Purpura: How Complex Is It?

Semple J.

Pathogenic T-Cell Responses in Patients with Autoimmune Thrombocytopenic Purpura

Crow AR,
Lazarus A

The role of FcGamma Receptors in the Pathogenesis and Treatment of ITP

Kekomäki R

Platelet Function and Immune Response

Kühne T

Investigation and Management of Newly Diagnosed Childhood Idiopathic Thrombocytopenic Purpura: Problems and Proposed Solutions

Blanchette V,
Price V

Childhood Chronic Immune Thrombocytopenic Purpura: Unresolved Issues

Provan D, Newland A

Immune Thrombocytopenic Purpura in Adults

Salama A

Alloimmune Thrombocytopenias

Buchanan G

Bleeding Signs in Children with Idiopathic Thrombocytopenic Purpura

Bolton-Maggs P

Severe Bleeding in Idiopathic Thrombocytopenic Purpura

Cines D et al.

Mechanisms of Action of Therapeutics in Idiopathic Thrombocytopenic Purpura

McMillan R

Antiplatelet Antibodies in Chronic Adult Immune Thrombocytopenic Purpura: Assays and Epitopes

Klaassen R

Using Decision Analysis Techniques to Deal With Unanswerable' Questions in Idiopathic Thrombocytopenic Purpura

Bullinger M et al.

Quality of Life in Children and Families with Bleeding Disorders

Imbach P et al.

Local and cultural Aspects of Childhood Idiopathic Thrombocytopenic Purpura: A Summary of Statements from the 12 Countries Worldwide

Imbach P et al.

New Developments in Idiopathic Thrombocytopenic Purpura: Cooperative, Prospective Studies by the Intercontinental Cooperative ITP Study Group

Freedman J

ITP: An Overview of the Conference and Future Directions with an Abbreviated ITP History

Order on Wiley InterScience

Search & Find